Cargando…

Assessing the prices and affordability of oncology medicines for three common cancers within the private sector of South Africa

BACKGROUND: Prices of cancer medicines are a major contributor to the cost of treatment for cancer patients and the comparison of these cost needs to be assessed. OBJECTIVES: To assess the prices of cancer medicines for the three most common cancers ((breast, prostate and colorectal) in the private...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mattila, Phyllis Ocran, Babar, Zaheer-Ud-Din, Suleman, Fatima
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8259378/ https://www.ncbi.nlm.nih.gov/pubmed/34229693 http://dx.doi.org/10.1186/s12913-021-06627-6

Ejemplares similares

A comprehensive survey of cancer medicines prices, availability and affordability in Ghana
por: Ocran Mattila, Phyllis, et al.
Publicado: (2023)

Availability, Affordability, Access, and Pricing of Anti-cancer Medicines in Low- and Middle-Income Countries: A Systematic Review of Literature
por: Ocran Mattila, Phyllis, et al.
Publicado: (2021)

WHO key access antibiotics price, availability and affordability in private sector pharmacies in Pakistan
por: Saleem, Zikria, et al.
Publicado: (2021)

Evaluating Drug Prices, Availability, Affordability, and Price Components: Implications for Access to Drugs in Malaysia
por: Babar, Zaheer Ud Din, et al.
Publicado: (2007)

Affordability of essential medicine prices in Malaysia’s private health sector
por: Ahmad, Nur Sufiza, et al.
Publicado: (2018)

Price, availability and affordability of medicines
por: Mhlanga, Brenda S., et al.
Publicado: (2014)

Is there transparency in the pricing of medicines in the South African private sector?
por: Bangalee, V, et al.
Publicado: (2018)

The Availability, Pricing, and Affordability of Essential Diabetes Medicines in 17 Low-, Middle-, and High-Income Countries
por: Babar, Zaheer-Ud-Din, et al.
Publicado: (2019)

Evaluating medicine prices, availability and affordability in Bangladesh using World Health Organisation and Health Action International methodology
por: Kasonde, Lombe, et al.
Publicado: (2019)

Evaluation of prices, availability and affordability of essential medicines in Lahore Division, Pakistan: A cross-sectional survey using WHO/HAI methodology
por: Saeed, Amna, et al.
Publicado: (2019)

Prices of oncology medicines in European countries, Australia and New Zealand
por: Vogler, Sabine, et al.
Publicado: (2015)

Forming a medicines pricing policy for low and middle-income countries (LMICs): the case for Pakistan
por: Babar, Zaheer-Ud-Din
Publicado: (2022)

Retail pharmacy prescription medicines’ availability, prices and affordability in Eswatini
por: Shambira, Garikai, et al.
Publicado: (2021)

Access to Insulin Products in Pakistan: A National Scale Cross-Sectional Survey on Prices, Availability, and Affordability
por: Saeed, Amna, et al.
Publicado: (2022)

The effects of pricing policy on the prices and supply of low-cost medicines in Shandong, China: evidence from an interrupted time series analysis
por: Rong, Xuejing, et al.
Publicado: (2020)

Challenges and opportunities for pharmaceutical pricing and reimbursement policies
por: Vogler, Sabine, et al.
Publicado: (2015)

Vaccine Prices: A Systematic Review of Literature
por: Hussain, Rabia, et al.
Publicado: (2020)

Understanding the decision making process of selection of medicines in the private sector in South Africa – lessons for low-middle income countries
por: Perumal-Pillay, Velisha Ann, et al.
Publicado: (2020)

Affordability Assessment from a Static to Dynamic Concept: A Scenario-Based Assessment of Cardiovascular Medicines
por: Zarei, Leila, et al.
Publicado: (2020)

Access to Essential Cardiovascular Medicines in Pakistan: A National Survey on the Availability, Price, and Affordability, Using WHO/HAI Methodology
por: Saeed, Amna, et al.
Publicado: (2021)

New Zealand consumers’ perceptions of private insurance for pharmaceuticals
por: Ragupathy, Rajan, et al.
Publicado: (2014)

The impact of generics and generic reference pricing on candesartan and rosuvastatin utilisation, price and expenditure in South Africa
por: de Jager, Henk, et al.
Publicado: (2018)

Evaluating Price and Availability of Essential Medicines in China: A Mixed Cross-Sectional and Longitudinal Study
por: Yang, Caijun, et al.
Publicado: (2020)

Availability, prices and affordability of essential medicines for treatment of diabetes and hypertension in private pharmacies in Zambia
por: Kaiser, Andrea Hannah, et al.
Publicado: (2019)

Affordable Prices Without Threatening the Oncological R&D Pipeline—An Economic Experiment on Transparency in Price Negotiations
por: Franzen, Nora, et al.
Publicado: (2022)

Association between medicine Price declaration by pharmaceutical industries and retail prices in Malaysia’s private healthcare sector
por: Ahmad, Nur Sufiza, et al.
Publicado: (2019)

Pharmaceutical policies in Australia and New Zealand
por: Babar, Zaheer-Ud-Din
Publicado: (2015)

The Need for an Evidence-Based Encyclopaedia in Health Services Research in Pharmacy
por: Babar, Zaheer-Ud-Din
Publicado: (2020)

Ten recommendations to improve pharmacy practice in low and middle-income countries (LMICs)
por: Babar, Zaheer-Ud-Din
Publicado: (2021)

Relationship between pharmaceutical pricing strategies with price, availability, and affordability of cardiovascular disease medicines: surveys in Qatar and Lebanon
por: Abdel Rida, N., et al.
Publicado: (2019)

Medicine Prices, Availability, and Affordability in Private Health Facilities in Low-Income Settlements in Nairobi County, Kenya
por: Ongarora, Dennis, et al.
Publicado: (2019)

New TB Tools Need to be Affordable in the Private Sector: The Case Study of Xpert MTB/RIF
por: Ponnudurai, Nirros, et al.
Publicado: (2018)

Systematic literature review of integrated community case management and the private sector in Africa: Relevant experiences and potential next steps
por: Awor, Phyllis, et al.
Publicado: (2014)

Overcoming the affordability barrier for effective and high quality life saving malaria medicines in the private sector in rural Uganda: the Consortium for ACT Private Sector Subsidy (CAPSS) pilot study
por: Talisuna, Ambrose O, et al.
Publicado: (2012)

Open access: What price affordability?
por: Poynder, Richard
Publicado: (2014)

An international analysis of the price and affordability of beer
por: Blecher, Evan, et al.
Publicado: (2018)

Prices, availability and affordability of medicines in Rwanda
por: Bizimana, Thomas, et al.
Publicado: (2020)

Treatment outcomes of extrapulmonary tuberculosis in Bahawalpur, Pakistan; a record review
por: Atif, Muhammad, et al.
Publicado: (2020)

Identifying priority medicines policy issues for New Zealand: a general inductive study
por: Babar, Zaheer-Ud-Din, et al.
Publicado: (2014)

Mapping the pharmaceutical situation in your country: First things first...
por: Babar, Zaheer-Ud-din, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_7jijsptlk3q43nqau9chtsph1m